Safety and Tolerability of NNC0114-0006 at Increasing Dose Levels in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this dose-escalating trial is to assess the
safety and tolerability of multiple doses of NNC0114-0006 in subjects with rheumatoid
arthritis (RA).